Analyst Research

Report Title Price
D Pharm Ltd: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
$20.00
Buy
D-Pharm Ltd. (DPRM) - Financial Analysis Review
Provider: GlobalData
$125.00
Buy
D-Pharm Ltd. (DPRM) - Financial Analysis Review
Provider: GlobalData
$125.00
Buy
D-Pharm Ltd. (DPRM) - Financial Analysis Review
Provider: GlobalData
$125.00
Buy

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

» More Analyst Research

D Pharm Ltd Announces Retirement of Chairman, Mr. Ruben Krupik; Appoints Mr. Aharon Schwartz as Replacement-Complete Story


Sunday, 12 Aug 2012 08:00pm EDT 

D Pharm Ltd announced that its Chairman, Mr. Ruben Krupik, has retired from the Company effective August 13, 2012. The Company has appointed Mr. Aharon Schwartz as its new Chairman, with effect from August 13, 2012. 

Latest Developments for D Pharm Ltd

Latest Key Developments in Biotechnology

Company Quote

D Pharm Ltd
(DPRM.TA)
58.0
-3.4 -5.40%
21 May 2013